The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub, D Kubitza… - Nature Reviews Drug …, 2011 - nature.com
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

[PDF][PDF] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub, D Kubitza… - NATURE REVIEWS …, 2011 - academia.edu
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub, D Kubitza… - Nature Reviews Drug …, 2011 - go.gale.com
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.

E Perzborn, S Roehrig, A Straub, D Kubitza… - Nature reviews. Drug …, 2010 - europepmc.org
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.

E Perzborn, S Roehrig, A Straub… - Nature Reviews …, 2011 - search.ebscohost.com
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

[引用][C] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub, D Kubitza… - Nature Reviews Drug …, 2010 - cir.nii.ac.jp
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[PDF][PDF] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub… - NAtURe ReVIeWs …, 2011 - researchgate.net
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub… - Nature reviews …, 2011 - pubmed.ncbi.nlm.nih.gov
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

[PDF][PDF] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub, D Kubitza… - NATURE REVIEWS …, 2011 - academia.edu
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

[引用][C] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub… - Nature Reviews …, 2011 - Nature Publishing Group